Related Experiment Video
Updated: Jul 17, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Diagnosis and treatment of the major hepatotropic viruses
1Department of Internal Medicine, University of Virginia, Charlottesville.
Insights
Hepatitis viruses A through E cause liver disease. While A and E cause acute injury, B, C, and D can lead to chronic conditions like cancer, requiring ongoing research for better treatments.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- Hepatotropic viruses (Hepatitis A, B, C, D, E) cause diverse liver diseases.
- Understanding their epidemiology and natural history is crucial for patient management.
- Evolving diagnostic assays impact the detection and understanding of these infections.
Purpose of the Study:
- To review the epidemiology, natural history, and clinical presentations of hepatitis viruses A-E.
- To discuss current and emerging diagnostic and therapeutic strategies.
- To highlight the impact of these viruses on liver health and disease progression.
Main Methods:
- Comprehensive literature review of hepatotropic viral infections.
- Analysis of current serodiagnostic and virologic assay capabilities.
- Discussion of established and investigational treatment modalities.
Main Results:
- Hepatitis A and E cause acute liver injury, managed via vaccination.
- Hepatitis B, C, and D can result in chronic liver disease, including cirrhosis and hepatocellular carcinoma.
- Interferon is a current therapy, with other antiviral strategies under investigation.
- Liver transplantation is an option for advanced disease, but viral recurrence is a significant challenge.
Conclusions:
- Continued molecular, epidemiologic, and clinical research is essential for improved diagnosis and management of viral hepatitis.
- Vaccination remains key for preventing Hepatitis A and E.
- Effective management of chronic Hepatitis B, C, and D requires ongoing therapeutic innovation and strategies to combat viral recurrence post-transplantation.
Abstract:
The hepatotropic viruses currently include hepatitis A, B, C, D, and E, and are associated with a spectrum of acute and chronic liver disease syndromes. The epidemiology and natural history of each are discussed, with emphasis on uncommon or newly recognized clinical presentations. The serodiagnosis of hepatitis A, B, and D is well established; the serodiagnosis of hepatitis C and E continues to evolve as serologic and virologic assays become refined. Hepatitis A and E only cause acute liver injury; current medical approaches therefore focus on vaccination strategies. Hepatitis B, C, and D can cause both acute and chronic liver injury. Sequelae of chronic liver disease, including portal hypertension and hepatocellular carcinoma, are not uncommon. Medical therapy of resulting chronic liver disease currently consists of interferon, though other anti-viral strategies are being explored. Advanced chronic liver disease due to hepatitis B, C, or D can be treated by orthotopic liver transplantation, but viral recurrence is near uniform and can be problematic. Further study of the hepatotropic viruses at the molecular biologic, epidemiologic, and clinical levels will continue to provide greater insight into the diagnosis and management of their associated clinical syndromes.
Related Concept Videos
Viruses with RNA Genomes
Cytomegalovirus Disease
Hepatitis
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors
Viral Hepatitis I: Introduction

